Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination.
Saved in:
| Title: | Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination. |
|---|---|
| Authors: | Ciérvide, Raquel1 (AUTHOR) raquel.ciervide@gmail.com, Montero, Ángel1 (AUTHOR), García-Rico, Eduardo2 (AUTHOR) raquel.ciervide@gmail.com, García-Aranda, Mariola1 (AUTHOR), Herrero, Mercedes3 (AUTHOR), Skaarup, Jessica3 (AUTHOR), Benassi, Leticia3 (AUTHOR), Barrera, Maria José3 (AUTHOR), Vega, Estela2 (AUTHOR), Rojas, Beatriz2 (AUTHOR), Bratos, Raquel2 (AUTHOR), Luna, Ana2 (AUTHOR), Parras, Manuela4 (AUTHOR), López, María4 (AUTHOR), Delgado, Ana4 (AUTHOR), Quevedo, Paloma4 (AUTHOR), Castilla, Silvia4 (AUTHOR), Feyjoo, Margarita5 (AUTHOR), Higueras, Ana6 (AUTHOR), Prieto, Mario7 (AUTHOR) |
| Source: | Cancers. Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
